8-K filing — Alkermes plc. (ALKS)
Filed: 2026-08-12 AccNo: 0001193125-26-345901 Size: 3 MB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
Stocks · News reference
Alkermes Q2 Sales $496.009M Beat $457.818M Estimate
Alkermes (NASDAQ:ALKS) reported quarterly sales of $496.009 million which beat the analyst consensus estimate of $457.818 million by 8.34 percent. This is a 26.97 percent increase over sales of $390.657 million the
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
8-K/A filing — Alkermes plc. (ALKS)
Filed: 2026-08-03 AccNo: 0001193125-26-330564 Size: 188 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
JP Morgan Maintains Neutral on Alkermes, Raises Price Target to $61
Baird Maintains Outperform on Alkermes, Raises Price Target to $58